Article
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.
PLoS pathogens - 1 Nov 2009
Perales Celia, Agudo Rubén, Tejero Hector, Manrubia Susanna C, Domingo Esteban
Abstract excerpt
Lethal mutagenesis is an antiviral strategy consisting of virus extinction associated with enhanced mutagenesis. The use of non-mutagenic antiviral inhibitors has faced the problem of selection of inhibitor-resistant virus mutants. Quasispecies dynamics predicts, and clinical results have confirmed, that combination therapy has an advantage over monotherapy to delay or prevent selection of inhibitor-escape...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
